Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 15.4B | 15.0B | 15.0B | 14.2B |
Cost of revenue | 13.1B | 12.5B | 12.8B | 11.8B |
Gross profit | 2.4B | 2.5B | 2.2B | 2.5B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 946.5M | 1.1B | 829.4M | 1.3B |
Operating income | 1.2B | 1.1B | 1.0B | 924M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 472.2M | 313.1M | 322.5M | 339.4M |
Other income expense | — | — | — | — |
Pretax income | 577.8M | 592.3M | 545.9M | 402.6M |
Tax provision | -26.9M | 31.5M | 34.5M | 31.7M |
Net income | 604.7M | 560.8M | 511.4M | 370.9M |
Basic EPS | — | 3.3 | 3.0 | 2.2 |
Diluted EPS | — | 3.3 | 3.0 | 2.2 |
Basic average shares | — | 168.4M | 168.2M | 167.8M |
Diluted average shares | — | 171.0M | 168.2M | 168.6M |
EBITDA | 1.5B | 1.4B | 1.4B | 1.2B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |